Carbon Monoxide Poisoning Author: Jeffrey T. Chapman, MD
Editorial changes - 2009-10-30
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Glossary
ABG
arterial blood gas
CAD
coronary artery disease
CBC
complete blood count
CHF
congestive heart failure
CI
confidence interval
CO
carbon monoxide
CT
computed tomography
CXR
chest x-ray
ECG
electrocardiography
HbO2
oxyhemoglobin
HBOT
hyperbaric oxygen therapy
HbCO
carboxyhemoglobin
MRI
magnetic resonance imaging
NBOT
normobaric oxygen therapy
ppm
parts per million
PO 2
partial pressure of oxygen
PCO 2
partial pressure of carbon dioxide
RCT
randomized controlled trial
WBC
white blood cell (leukocyte)
Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.